
In the midst of speculation that a U.S. missionary was treated with its experimental therapeutic, B.C.-based pharmaceutical developer Tekmira denies that anyone outside of the now on-hold clinical trial has been given the drug.

In the midst of speculation that a U.S. missionary was treated with its experimental therapeutic, B.C.-based pharmaceutical developer Tekmira denies that anyone outside of the now on-hold clinical trial has been given the drug.